Bezafibrate
Top View
- 1. NAME of the MEDICINAL PRODUCT Fluvastatin 20 Mg / 40
- Antidiabetic Action of Bezafibrate in a Large Observational Database
- Development of a LC-MS/MS Method for the Estimation of Clinofibrate In
- Newer Approaches to the Management of Pruritus in Cholestatic Liver Disease
- PPAR Agonist Fenofibrate Suppresses Tumor Growth Through Direct
- Elucidation of Molecular Mechanism of a Selective PPAR Modulator
- Lipid Management in Patients with Endocrine Disorders: an Endocrine
- Pharmaceutical Composition Comprising a Combination Of
- Prevention of Murine Atherosclerosis with Bempedoic Acid
- PPAR-Mediated Toxicology and Applied Pharmacology
- Cardiovascular Diabetology Biomed Central
- Bezalip and Bezalip Retard CMI
- Ezetimibe for Lowering Blood Cholesterol
- Package Leaflet: Information for the Patient Fenofibrate 200 Mg
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Fibrates (Fi – Brates)
- Bezafibrate Induced Rhabdomyolysis
- Lipid Modification to Reduce Cardiovascular Risk